These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8098525)

  • 21. Mechanism of the deadly quartet.
    Deedwania PC
    Can J Cardiol; 2000 Aug; 16 Suppl E():17E-20E. PubMed ID: 10906620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypertension, insulin resistance and diabetes mellitus: pathophysiological interactions and therapeutic consequences].
    Schernthaner G
    Wien Klin Wochenschr; 1990 Dec; 102(24):707-12. PubMed ID: 1980767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertension and insulin disorders.
    Imazu M
    Curr Hypertens Rep; 2002 Dec; 4(6):477-82. PubMed ID: 12419178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Manipulating the vascular biology of coronary atherosclerosis in diabetes: new opportunities.
    Orford JL; Kinlay S; Fernandes J; Behrendt D; Ganz P; Selwyn AP
    J Lab Clin Med; 2001 Feb; 137(2):82-92. PubMed ID: 11174464
    [No Abstract]   [Full Text] [Related]  

  • 26. [How to use anti-hypertensive medication in management of diabetic patients].
    Hirose H; Saito I
    Nihon Rinsho; 2003 Jul; 61(7):1205-9. PubMed ID: 12877086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Coronary artery disease in patients with diabetes mellitus and its treatment].
    Teramoto T
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():94-9. PubMed ID: 11989270
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypertension, coronary artery disease and insulin resistance--linked disorders with an impact on treatment.
    Florkowski CM; Harrison J; Kendall MJ
    J Clin Pharm Ther; 1992 Jun; 17(3):147-54. PubMed ID: 1639876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of doxazosin on insulin resistance in hypertensive patients with obesity.
    Ueshiba H; Miyachi Y
    Horm Metab Res; 2003 Sep; 35(9):532-6. PubMed ID: 14517769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
    Pedersen O
    Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is hypertension an insulin-resistant state? Metabolic changes associated with hypertension and antihypertensive therapy.
    Sowers JR
    Am Heart J; 1991 Sep; 122(3 Pt 2):932-5. PubMed ID: 1877473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypertension in patients with diabetes mellitus--selected pathogenetic and therapeutic aspects].
    Zukowska-Szczechowska E; Tomaszewski M; Grzeszczak W
    Przegl Lek; 2001; 58(3):124-6. PubMed ID: 11475857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
    Scheen AJ
    Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Theoretical aspects of the relationship between diabetic macroangiopathy and hyperinsulinism].
    Leutenegger M
    Presse Med; 1992 Sep; 21(28):1324-9. PubMed ID: 1438101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension: are beta-blockers and diuretics appropriate first-line therapies?
    Wilson MD; Weart CW
    Ann Pharmacother; 1994 May; 28(5):617-25. PubMed ID: 7915151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes and cancer: a 2013 synopsis.
    Buysschaert M; Sadikot S
    Diabetes Metab Syndr; 2013; 7(4):247-50. PubMed ID: 24290094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of hypertension associated with diabetes mellitus].
    Katayama S
    Nihon Rinsho; 1997 Aug; 55(8):2091-6. PubMed ID: 9284429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study.
    Eriksson JW; Jansson PA; Carlberg B; Hägg A; Kurland L; Svensson MK; Ahlström H; Ström C; Lönn L; Ojbrandt K; Johansson L; Lind L
    Hypertension; 2008 Dec; 52(6):1030-7. PubMed ID: 18981327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hypertension and insulin resistance in obese type 2 diabetic Wistar fatty rat].
    Suzuki M; Odaka H
    Nihon Rinsho; 2003 Jul; 61(7):1119-23. PubMed ID: 12877072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.